US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 4.330
  • -0.070-1.59%
Close Apr 25 16:00 ET
  • 4.330
  • 0.0000.00%
Post 16:20 ET
267.47MMarket Cap-3160P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.15%75.65M
16.77%22.81M
6.87%18.07M
6.52%16.39M
9.09%18.37M
21.24%68.68M
4.14%19.53M
18.58%16.91M
21.62%15.39M
53.47%16.84M
Selling and administrative expenses
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
-3.97%4.72M
21.40%5.38M
15.01%5.03M
-General and administrative expense
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
10.04%20.83M
9.41%5.7M
-3.97%4.72M
21.40%5.38M
15.01%5.03M
Research and development costs
14.63%54.85M
29.96%17.98M
9.43%13.34M
16.58%11.67M
0.36%11.86M
26.85%47.85M
2.11%13.84M
30.44%12.19M
21.74%10.01M
78.92%11.81M
Operating profit
-10.15%-75.65M
-16.77%-22.81M
-6.87%-18.07M
-6.52%-16.39M
-9.09%-18.37M
-21.24%-68.68M
-4.14%-19.53M
-18.58%-16.91M
-21.62%-15.39M
-53.47%-16.84M
Net non-operating interest income expense
133.01%4.5M
53.37%1.25M
92.13%1.42M
161.37%839K
1,565.00%999K
816.11%1.93M
1,795.35%815K
1,468.09%737K
453.45%321K
-4.76%60K
Non-operating interest income
257.04%7.84M
325.53%4.58M
92.13%1.42M
161.37%839K
1,565.00%999K
940.28%2.2M
2,404.65%1.08M
1,468.09%737K
453.45%321K
-4.76%60K
Non-operating interest expense
1,172.14%3.33M
----
----
----
----
--262K
----
----
----
----
Other net income (expense)
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
-203.08%-197K
-435.09%-191K
25.53%-105K
Other non- operating income (expenses)
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
-68.78%-319K
535.00%174K
-203.08%-197K
-435.09%-191K
25.53%-105K
Income before tax
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
Income tax
Net income
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
Net income continuous Operations
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
Minority interest income
Net income attributable to the parent company
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
-14.65%-16.37M
-21.70%-15.26M
-52.80%-16.88M
Basic earnings per share
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
36.67%-0.38
28.30%-0.38
-51.06%-0.71
Diluted earnings per share
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
0.00%-1.78
-147.06%-0.42
36.67%-0.38
28.30%-0.38
-51.06%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.15%75.65M16.77%22.81M6.87%18.07M6.52%16.39M9.09%18.37M21.24%68.68M4.14%19.53M18.58%16.91M21.62%15.39M53.47%16.84M
Selling and administrative expenses -0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M-3.97%4.72M21.40%5.38M15.01%5.03M
-General and administrative expense -0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M10.04%20.83M9.41%5.7M-3.97%4.72M21.40%5.38M15.01%5.03M
Research and development costs 14.63%54.85M29.96%17.98M9.43%13.34M16.58%11.67M0.36%11.86M26.85%47.85M2.11%13.84M30.44%12.19M21.74%10.01M78.92%11.81M
Operating profit -10.15%-75.65M-16.77%-22.81M-6.87%-18.07M-6.52%-16.39M-9.09%-18.37M-21.24%-68.68M-4.14%-19.53M-18.58%-16.91M-21.62%-15.39M-53.47%-16.84M
Net non-operating interest income expense 133.01%4.5M53.37%1.25M92.13%1.42M161.37%839K1,565.00%999K816.11%1.93M1,795.35%815K1,468.09%737K453.45%321K-4.76%60K
Non-operating interest income 257.04%7.84M325.53%4.58M92.13%1.42M161.37%839K1,565.00%999K940.28%2.2M2,404.65%1.08M1,468.09%737K453.45%321K-4.76%60K
Non-operating interest expense 1,172.14%3.33M------------------262K----------------
Other net income (expense) 91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K-203.08%-197K-435.09%-191K25.53%-105K
Other non- operating income (expenses) 91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K-68.78%-319K535.00%174K-203.08%-197K-435.09%-191K25.53%-105K
Income before tax -6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M-52.80%-16.88M
Income tax
Net income -6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M-52.80%-16.88M
Net income continuous Operations -6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M-52.80%-16.88M
Minority interest income
Net income attributable to the parent company -6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M-52.80%-16.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M-14.65%-16.37M-21.70%-15.26M-52.80%-16.88M
Basic earnings per share 23.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.4236.67%-0.3828.30%-0.38-51.06%-0.71
Diluted earnings per share 23.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.40.00%-1.78-147.06%-0.4236.67%-0.3828.30%-0.38-51.06%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg